GlaxoSmithKline (CAI:BIOC) Inventories, Raw Materials & Components: E£0 Mil (As of Sep. 2016)


What is GlaxoSmithKline Inventories, Raw Materials & Components?

GlaxoSmithKline CAI:BIOC +1.69% Inventories, Raw Materials & Components is E£0 Mil as of Sep. 2016.

GlaxoSmithKline's inventories, raw materials & components for the quarter that ended in Sep. 2016 was E£0 Mil.

GlaxoSmithKline Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for GlaxoSmithKline's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GlaxoSmithKline Inventories, Raw Materials & Components Chart

GlaxoSmithKline Annual Data
Trend Dec12 Dec13 Dec14 Dec15
Inventories, Raw Materials & Components
0.00 0.00 0.00 0.00

GlaxoSmithKline Quarterly Data
Dec12 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

GlaxoSmithKline Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of E£0 Mil mean?
GlaxoSmithKline (CAI:BIOC) has a Inventories, Raw Materials & Components of E£0 Mil as of Sep. 2016. Raw materials are the components a company uses for its main products. View historical data on GlaxoSmithKline and its competitors.
Is GlaxoSmithKline's Inventories, Raw Materials & Components too high?
GlaxoSmithKline's current Inventories, Raw Materials & Components is E£0 Mil.
How does GlaxoSmithKline's Inventories, Raw Materials & Components compare to PRPH?
GlaxoSmithKline's Inventories, Raw Materials & Components of E£0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Drug Manufacturers company?
A good Inventories, Raw Materials & Components depends on the Drug Manufacturers industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on GlaxoSmithKline and its competitors. GlaxoSmithKline's current Inventories, Raw Materials & Components is E£0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GlaxoSmithKline stock overvalued right now?
GlaxoSmithKline (CAI:BIOC) has a current Inventories, Raw Materials & Components of E£0 Mil. The current Inventories, Raw Materials & Components is E£0 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For GlaxoSmithKline (CAI:BIOC), the current Inventories, Raw Materials & Components is E£0 Mil as of Sep. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GlaxoSmithKline Business Description

Address Boomerang Building, No 46, Block (J) First Section City Centre, Town Centre, Second floor, Fifth District - New Cairo, Cairo, EGY, 11835
GlaxoSmithKline is a pharmaceutical company. It is focused on developing new medicines in respiratory, HIV, oncology, and immune-inflation. The company is segmented into Commercial Operations and Total Research and development. It generates the majority of its revenue from the Commercial Operations segment.